Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 28:2:98.
doi: 10.12688/f1000research.2-98.v1. eCollection 2013.

Over 30 million psychedelic users in the United States

Teri S Krebs  1 , Pål-Ørjan Johansen  1
Affiliations

Over 30 million psychedelic users in the United States

Teri S Krebs et al. F1000Res. .

Abstract

We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychedelic users in the US in 2010; including 17% of people aged 21 to 64 years (22% of males and 12% of females). Rate of lifetime psychedelic use was greatest among people aged 30 to 34 (total 20%, including 26% of males and 15% of females).

PubMed Disclaimer

Conflict of interest statement

Competing interests: No competing interests were disclosed.

Figures

Figure 1.
Figure 1.. Lifetime psychedelic use by age and gender in the US in 2010.
Error bars show 95% confidence intervals. Any psychedelic includes LSD, psilocybin, mescaline, and/or peyote. Mescaline includes both mescaline and peyote.
See this image and copyright information in PMC

References

    1. Nichols DE: Hallucinogens. Pharmacol Ther. 2004;101(2):131–181 10.1016/j.pharmthera.2003.11.002 - DOI - PubMed
    1. González-Maeso J, Weisstaub NV, Zhou M, et al. : Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron. 2007;53(3):439–52 10.1016/j.neuron.2007.01.008 - DOI - PubMed
    1. Hallock RM, Dean A, Knecht ZA, et al. : A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. Drug Alcohol Depend. 2012;130(1–3):245–8 10.1016/j.drugalcdep.2012.11.010 - DOI - PubMed
    1. Andersson C, Kristinsson J, Gry J: Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids. Nordic Council of Ministers. 2009. Reference Source
    1. Johnston LD, O’Malley PM: The recanting of earlier reported drug use by young adults. NIDA Res Monogr. 1997;167:59–80 - PubMed